
Altimmune’s Latest Data Solidifies Pemvidutide as a Game-Changing Market Disruptor
Pemvidutide: A Potential Game-changer in Obesity Treatment Introduction Pemvidutide, a novel GLP-1 agonist, has been gaining attention for its promising results in the treatment of obesity and metabolic syndrome (MASH). With a unique mechanism of action, pemvidutide has shown the ability to preserve lean mass while effectively reducing visceral adipose tissue (VAT), making it a…